Osmotica Pharmaceutical Corp FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · May 7, 2014
  • No warning letters matched by name
Inspections 1 0 OAI
Recalls 4 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Osmotica Pharmaceutical Corp has 4 FDA recalls, 1 inspection, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Osmotica Pharmaceutical Corp" is on file.

What these totals cover: FDA records filed under the name "Osmotica Pharmaceutical Corp" and its spelling variants "Osmotica Pharmaceutical", "Osmotica Pharmaceutical Corporation".

Latest recall
D-0581-2018 · Class III · Feb 28, 2018
Latest inspection
May 7, 2014 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls4Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections1Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Osmotica Pharmaceutical Corp's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Osmotica Pharmaceutical Corp: FDA recall records per year

2017: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202400000
202300000
202200000
202100000
202000000
201900000
201800010
201700020

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Osmotica Pharmaceutical Corp as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Osmotica Pharmaceutical Corp yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

4 recall records from Sep 16, 2013 to Feb 28, 2018.

NumberClassProductDate
D-0581-2018Class IIIMethylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only…Feb 28, 2018
D-0110-2018Class IIIMethylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles, Rx Only…Dec 18, 2017
D-0111-2018Class IIIMethylphenidate Hydrochloride Extended-release Tablets, USP 54 mg, 100-count bottles, Rx Only…Dec 18, 2017
D-1067-2013Class IIIVenlafaxine (Venlafaxine Hydrochloride) extended release Tablets, 225 mg, packaged in a) 30- count…Sep 16, 2013

Recent FDA inspections

1 inspection on May 7, 2014.

DateSiteProductClassificationFEI
May 7, 2014Wilmington, NCDrugsNo Action Indicated (NAI)3005371242
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3005371242Wilmington, NC1May 7, 2014

Osmotica Pharmaceutical Corp and the FDA: common questions

Has Osmotica Pharmaceutical Corp received an FDA warning letter?

No FDA warning letter addressed to the name "Osmotica Pharmaceutical Corp" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Osmotica Pharmaceutical Corp received an FDA Form 483?

FDA has not published a Form 483 for "Osmotica Pharmaceutical Corp" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Osmotica Pharmaceutical Corp?

The most recent FDA inspection on file ended May 7, 2014 at Wilmington, NC and was classified NAI. FDA has 1 inspection of Osmotica Pharmaceutical Corp on file.

Has Osmotica Pharmaceutical Corp had an FDA recall?

Yes. Osmotica Pharmaceutical Corp has 4 FDA recalls on record. The most recent started Feb 28, 2018.

Need more than this page shows? Ask about Osmotica Pharmaceutical Corp in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.